Your browser doesn't support javascript.
loading
Ixekizumab and Ustekinumab Efficacy in Nail Psoriasis in Patients with Moderate-to-Severe Psoriasis: 52-Week Results from a Phase 3, Head-to-Head Study (IXORA-S).
Wasel, Norman; Thaçi, Diamant; French, Lars E; Conrad, Curdin; Dutronc, Yves; Gallo, Gaia; Berggren, Lovisa; Lacour, Jean-Philippe.
Afiliação
  • Wasel N; Stratica Medical and Probity Medical Research, Edmonton, AB, Canada. nwasel@straticamedical.com.
  • Thaçi D; Research Institute and Comprehensive Center for Inflammation Medicine, University of Lübeck, Lübeck, Germany.
  • French LE; Department of Dermatology and Allergy, University Hospital, Ludwig Maximilian University of Munich (LMU Munich), Munich, Germany.
  • Conrad C; Department of Dermatology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
  • Dutronc Y; Eli Lilly and Company, Indianapolis, IN, USA.
  • Gallo G; Eli Lilly and Company, Indianapolis, IN, USA.
  • Berggren L; HaaPACS GmbH, Schriesheim, Germany.
  • Lacour JP; Department of Dermatology, University Hospital of Nice-Côte d'Azur, Nice, France.
Dermatol Ther (Heidelb) ; 10(4): 663-670, 2020 Aug.
Article em En | MEDLINE | ID: mdl-32415575
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Dermatol Ther (Heidelb) Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Dermatol Ther (Heidelb) Ano de publicação: 2020 Tipo de documento: Article